Hold Sun Pharma, says Surajit Pal

Surajit Pal, pharma analyst at Prabhudas Lilladher told CNBC-TV18, "Sun Pharmaceutical Industries is always darling of the market. I believe given the kind of weightage it has nobody can deny it. So, I believe that if you are holding you should continue to hold. At this point of time if there is correction then you could make an entry but not make a new entry at the current valuation."

At 14:09 hrs Sun Pharmaceutical Industries was quoting at Rs 1,051.70, up Rs 11.85, or 1.14 percent. It has touched an intraday high of Rs 1,067 and an intraday low of Rs 1,042.70.